Navigation Links
QRxPharma Receives Positive Feedback from Scientific Advice Meetings in Europe on MoxDuo®IR Development and Registration
Date:7/26/2010

BEDMINSTER, N.J. and SYDNEY, July 26 /PRNewswire-FirstCall/ -- QRxPharma (ASX: QRX and Pink Sheets: QRXPY) reported today positive outcomes of its European Scientific Advice meetings on the development and registration of MoxDuo IR, an immediate release Dual-Opioid™ pain therapy. The Company is currently completing pivotal Phase 3 trials required for filing a New Drug Application (NDA) for MoxDuo IR with the United States Food and Drug Administration (FDA). QRxPharma intends to submit a Marketing Authorisation Application (MAA) in Europe, the second largest market (approximately US$3.5 billion) in the world for opioid analgesics. In support of these registration activities, the Company held Scientific Advice meetings in Germany and the United Kingdom in May 2010. Based on the positive responses in the official minutes of these meetings, QRxPharma intends to select Germany as the lead Agency for European MAA review, and will submit the application in 2011.

"Similar to the FDA's acceptance of our streamlined development plan for MoxDuo IR, feedback and guidance from the European Agencies regarding the suitability of our data package for MAA submission is also positive," said Dr. John Holaday, Managing Director and Chief Executive Officer, QRxPharma. "Our objective is to launch MoxDuo IR globally in 2012, and this feedback clears a significant hurdle and facilitates our European regulatory and commercialisation strategy."

In reply to questions posed by QRxPharma to the German Federal Institute for Drugs and Medical Devices (BfArM), the data package available from the U
'/>"/>

SOURCE QRXPharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
2. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
3. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
4. QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
5. QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuo(TM)CR
6. QRxPharma Limited Announces A$21.6 Million Fully Underwritten Capital Raising
7. QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission
8. QRxPharma Limited and China Aoxing Pharmaceutical Company Announce Strategic Alliance for Development of MoxDuo(R)IV
9. QRxPharma Releases Additional Pivotal Phase 3 Combination Rule Study Data for MoxDuo(R)IR in Patients with Post-Surgical Pain
10. QRxPharma Successfully Completes Comparative Phase 1 Proof-of-Concept Study for MoxDuo(R) CR Tablet Formulation
11. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015  Only a quarter of ... managing the patients they prescribe them to, according to ... School of Medicine (BUSM) and myCME , ... Daniel Alford, M.D. , director of BUSM,s ... program , said, "This indicates a critical need for ...
(Date:6/2/2015)... 2015  ErgoNurse, the leader in bedside safety management solutions, ... the United States , have formalized a ... and skilled nursing markets. ... Thousands of healthcare professionals ... advantage of the ErgoNurse products to stop unnecessarily utilizing their ...
(Date:6/2/2015)...  CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical ... that it has reached an agreement to settle the ... Court of Chancery, which names as defendants ... and officers, and names the Company as a nominal ... CytRx Corp. Stockholder Derivative Litigation , C.A. No. 9864-VCL, ...
Breaking Medicine Technology:Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4
... FRANCISCO, Feb. 19 Inverseon, Inc. ( http://www.inverseon.com ) ... of the Proceedings of the National Academy of Sciences ... of an asthma phenotype in a murine model." The ... Duke Professor of Medicine at Duke University , ...
... France, February 18 , ... in Latin,America and Asia , ... :,SAN and NYSE : SNY), announced today that its ... study in Thailand to,assess the efficacy of the vaccine ...
Cached Medicine Technology:Inverseon's Founder and SAB Member Published in PNAS 2Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study 2Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study 3Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study 4
(Date:6/2/2015)... ANT Wireless, proven innovator in ultra-low power (ULP) ... products implementing the ANT+ Fitness Equipment Control (FE-C) profile: ... their bike trainer products, built to create an exciting ... FE-C device profile in its Vortex Smart and Bushido ... training software, while Kinomap has added FE-C support to ...
(Date:6/2/2015)... MAP Health Management, LLC, a provider of outcome data, ... facilities, announced today that Jared Smith has joined the ... be responsible for developing and implementing a marketing strategy ... message, products and initiatives. , Prior to joining MAP, ... in Irving, Texas, where he was responsible for developing ...
(Date:6/2/2015)... June 02, 2015 DiaTech Oncology, ... response profiling test to help oncologists provide personalized ... of American Pathologists (CAP) for its laboratories in ... certification is equivalent to the ‘Good Housekeeping’ seal ... chief executive officer for DiaTech. “It’s a rigorous ...
(Date:6/2/2015)... For those that have ever worried ... harmful germs, chemicals and bodily fluids from each flush, ... inventor from Queens Village, N.Y., their worries are over. ... fun, hygienic way to store and dispense toothpaste. It ... chemicals and germs. Furthermore, it insures that all contents ...
(Date:6/2/2015)... Relias Learning , the leader ... healthcare market, is partnering with the National Council, ... courses relating to mental health and wellness. These ... resources to better understand and handle difficult situations. ... responders to situations involving people with mental illness ...
Breaking Medicine News(10 mins):Health News:First ANT FE-C Enabled Fitness Products Enter Market 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 3Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2Health News:DiaTech Oncology Gains College of American Pathologists Accreditation for U.S. CorrectChemo Laboratory 2Health News:Dental Storage and Dispensing Unit Invented by InventHelp Client (LGI-1890) 2Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 2Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 3
... Ireland, Sept. 10 Warner Chilcott plc (Nasdaq: ... filed two lawsuits against Lupin Limited and its wholly owned ... for the District of Delaware for infringement of Warner Chilcott,s ... ",050 Patent"), which cover oral contraceptives LOESTRIN 24 FE and ...
... treat major depression. Many antidepressant medications are available, but no single ... for an individual. As a result, for more than half of ... take months to figure out what does. Now, based on ... may be able to accurately predict within a week whether a ...
... FL (September 10, 2009) The University of Miami School of ... Dr. John T. Macdonald Foundation in the amount of $30,000 ... of Science of Nursing program. "Family nurse practitioners have a ... of Nursing and Health Studies. "The Dr. John T. Macdonald ...
... scourge poses a potential threat, just like swine flu , THURSDAY, ... the headlines, but seasonal flu poses a real threat this fall, ... a seasonal flu shot. Then follow it up with an H1N1 ... That was the message Thursday from U.S. health officials, who noted ...
... , , , ... of the H1N1 virus - the upcoming revisit of swine flu ... preparedness plans within the private sector. "There,s no question that companies ... "Businesses are navigating a daunting market and obstacles not immediately in ...
... PEMBROKE, Bermuda, Sept. 10 Allied World,Assurance Company ... that Allied,World,s Chief Operating Officer, David Bell, will be ... the Cityplace Conference Center in,Dallas, Texas on September 15, ... Symposium is organized by MarketScout, and,the theme of this ...
Cached Medicine News:Health News:Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents 2Health News:Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents 3Health News:Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents 4Health News:UCLA researchers develop biomarker for rapid relief of major depression 2Health News:UCLA researchers develop biomarker for rapid relief of major depression 3Health News:UM receives grant to support graduate students in the family nurse practitioner program 2Health News:Get Your Vaccine for Seasonal Flu, Experts Urge 2Health News:Get Your Vaccine for Seasonal Flu, Experts Urge 3Health News:H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 2Health News:Allied World's David Bell to Present as Keynote Speaker at 2009 Entrepreneurial Insurance Symposium 2Health News:Allied World's David Bell to Present as Keynote Speaker at 2009 Entrepreneurial Insurance Symposium 3
Electrohydraulic Lithotripsy Probe for AEH-4...
Short double-horn bridge for insertion of instruments...
... Tipless Design, ZeroTip basket ... smooth negotiation and close stone approximation., ... scope deflection for efficient retrieval of ... When passed through a 3.6Fr working ...
... stone manipulation and removal in the urinary tract. ... Wire. The revolutionary triangular shape of Delta Wire ... possible wire mass. The superior mass of the ... of nitinol alloy, creates a basket with increased ...
Medicine Products: